{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:52:24Z","timestamp":1649026344677},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10354-006-0315-4","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T14:06:26Z","timestamp":1156514786000},"page":"397-403","source":"Crossref","is-referenced-by-count":1,"title":["Portal hypertension \u2013 old problem, new therapeutic solutions"],"prefix":"10.1007","volume":"156","author":[{"given":"Markus","family":"Peck-Radosavljevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","volume":"39","author":"RJ Groszmann","year":"2004","unstructured":"Groszmann RJ, Wongcharatrawee S (2004) The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39: 280\u2013282","journal-title":"Hepatology"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/gast.2001.22580","volume":"120","author":"G Garcia-Tsao","year":"2001","unstructured":"Garcia-Tsao G (2001) Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120: 726\u2013748","journal-title":"Gastroenterology"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","volume":"43","author":"R de Franchis","year":"2005","unstructured":"de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43: 167\u2013176","journal-title":"J Hepatol"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1055\/s-2005-861464","volume":"37","author":"M Peck-Radosavljevic","year":"2005","unstructured":"Peck-Radosavljevic M, Trauner M, Schreiber F (2005) Austrian consensus on the definition and treatment of portal hypertension and its complications. Endoscopy 37: 667\u2013673","journal-title":"Endoscopy"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A et al (2005) Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. N Engl J Med 353: 2254\u20132261","journal-title":"N Engl J Med"},{"key":"315_CR6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2004.05.004","volume":"127","author":"C Merkel","year":"2004","unstructured":"Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, Cavallarin G et al (2004) A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127: 476\u2013484","journal-title":"Gastroenterology"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jhep.2001.23054","volume":"33","author":"TF Imperiale","year":"2001","unstructured":"Imperiale TF, Chalasani N (2001) A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33: 802\u2013807","journal-title":"Hepatology"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.20284","volume":"40","author":"M Schepke","year":"2004","unstructured":"Schepke M, Kleber G, Nurnberg D, Willert J, Koch L, Veltzke-Schlieker W, Hellerbrand C et al (2004) Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 40: 65\u201372","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"315_CR9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(02)00430-0","volume":"38","author":"J Bosch","year":"2003","unstructured":"Bosch J, Abraldes JG, Groszmann R (2003) Current management of portal hypertension. J Hepatol 38 (Suppl 1): 54\u201368","journal-title":"J Hepatol"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.seminhematol.2003.11.003","volume":"41","author":"J Bosch","year":"2004","unstructured":"Bosch J, Abraldes JG (2004) Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Semin Hematol 41: 8\u201312","journal-title":"Semin Hematol"},{"key":"315_CR11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","volume":"29","author":"B Bernard","year":"1999","unstructured":"Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29: 1655\u20131661","journal-title":"Hepatology"},{"key":"315_CR12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0168-8278(01)00206-9","volume":"35","author":"E Moitinho","year":"2001","unstructured":"Moitinho E, Planas R, Banares R, Albillos A, Ruiz-del-Arbol L, Galvez C, Bosch J (2001) Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol 35: 712\u2013718","journal-title":"J Hepatol"},{"key":"315_CR13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","volume":"361","author":"J Bosch","year":"2003","unstructured":"Bosch J, Garcia-Pagan JC (2003) Prevention of variceal rebleeding. Lancet 361: 952\u2013954","journal-title":"Lancet"},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/gast.2002.35955","volume":"123","author":"D Patch","year":"2002","unstructured":"Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, Burroughs AK (2002) A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 123: 1013\u20131019","journal-title":"Gastroenterology"},{"key":"315_CR15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa003223","volume":"345","author":"C Villanueva","year":"2001","unstructured":"Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S et al (2001) Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 345: 647\u2013655","journal-title":"N Engl J Med"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hep.20584","volume":"41","author":"J de la Pena","year":"2005","unstructured":"de la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suarez C (2005) Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41: 572\u2013578","journal-title":"Hepatology"},{"key":"315_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jhep.2000.16236","volume":"32","author":"GH Lo","year":"2000","unstructured":"Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, Lin CK (2000) Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32: 461\u2013465","journal-title":"Hepatology"},{"key":"315_CR18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","volume":"40","author":"A Monescillo","year":"2004","unstructured":"Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, Marrero JM et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40: 793\u2013801","journal-title":"Hepatology"},{"key":"315_CR19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","volume":"39","author":"BA Runyon","year":"2004","unstructured":"Runyon BA (2004) Management of adult patients with ascites due to cirrhosis. Hepatology 39: 841\u2013856","journal-title":"Hepatology"},{"key":"315_CR20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB et al (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23: 164\u2013176","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"315_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2036.16.s5.4.x","volume":"16","author":"P Gines","year":"2002","unstructured":"Gines P, Guevara M, De Las Heras D, Arroyo V (2002) Review article: albumin for circulatory support in patients with cirrhosis. Aliment Pharmacol Ther 16 (Suppl 5): 24\u201331","journal-title":"Aliment Pharmacol Ther"},{"key":"315_CR22","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","volume":"350","author":"P Gines","year":"2004","unstructured":"Gines P, Cardenas A, Arroyo V, Rodes J (2004) Management of cirrhosis and ascites. N Engl J Med 350: 1646\u20131654","journal-title":"N Engl J Med"},{"key":"315_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32: 142\u2013153","journal-title":"J Hepatol"},{"key":"315_CR24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis [see comments]. N Engl J Med 341: 403\u2013409","journal-title":"N Engl J Med"},{"key":"315_CR25","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gines","year":"2003","unstructured":"Gines P, Guevara M, Arroyo V, Rodes J (2003) Hepatorenal syndrome. Lancet 362: 1819\u20131827","journal-title":"Lancet"},{"key":"315_CR26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"C Duvoux","year":"2002","unstructured":"Duvoux C, Zanditenas D, Hezode C, Chauvat A, Monin JL, Roudot-Thoraval F, Mallat A et al (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36: 374\u2013380","journal-title":"Hepatology"},{"key":"315_CR27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","volume":"35","author":"P Ferenci","year":"2002","unstructured":"Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35: 716\u2013721","journal-title":"Hepatology"},{"key":"315_CR28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","volume":"34","author":"K Weissenborn","year":"2001","unstructured":"Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34: 768\u2013773","journal-title":"J Hepatol"},{"key":"315_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/jhep.2002.30957","volume":"35","author":"G Kircheis","year":"2002","unstructured":"Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35: 357\u2013366","journal-title":"Hepatology"},{"key":"315_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","volume":"25","author":"G Kircheis","year":"1997","unstructured":"Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R et al (1997) Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 25: 1351\u20131360","journal-title":"Hepatology"},{"key":"315_CR31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","volume":"28","author":"S Stauch","year":"1998","unstructured":"Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R, Hendricks R et al (1998) Oral Lornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled doubleblind study. J Hepatol 28: 856\u2013864","journal-title":"J Hepatol"},{"key":"315_CR32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.20905","volume":"42","author":"O Riggio","year":"2005","unstructured":"Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, Nicolao F et al (2005) High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology 42: 1158\u20131165","journal-title":"Hepatology"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0315-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-006-0315-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0315-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:39Z","timestamp":1559145819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-006-0315-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":32,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s10354-006-0315-4","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}